Visceral Leishmaniasis Clinical Trial
Official title:
Improved Visceral Leishmaniasis (VL) Case Detection and Vector Control to Support the VL Elimination Initiative in Bangladesh
NCT number | NCT03269006 |
Other study ID # | PR-14087 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 1, 2016 |
Est. completion date | July 30, 2019 |
Verified date | December 2019 |
Source | International Centre for Diarrhoeal Disease Research, Bangladesh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Visceral leishmaniasis (VL) also known as kala-azar is a public health problem in Bangladesh.
Since 2005 a national kala-azar elimination program is going on in the country. The program
has preparatory, attack, consolidation and maintenance phases. The target of the program is
to reduce the VL incidence less than 1 per 10,000 people at upazila (sub-district) level in
VL endemic upazilas of the country. The program is heading successfully to its consolidation
phase.
During attack phase house to house search for VL suspects and also suspects with
Post-kala-azar Dermal Leishmaniasis (PKDL) was the tool for early diagnosis of VL and PKDL
cases. Indoor residual spraying with insecticide (Deltamethrin) was the method for sand fly
control to reduce the transmission of the disease. Since in the consolidation phase the VL
case load is many times less than that in the attack phase, house to house search for VL and
PKDL cases and IRS for vector control is no more cost-effective for the program. Therefore
there is a need for alternative methods for active search of VL and PKDL cases and method for
sand fly control, appropriate for the consolidation phase.
In the present study the investigators propose to investigate the efficacy of Inesfly 5AIGRNG
TM containing Alphacypermethrin 0.7%; D-Allethin 1.0% and Pyriproxyphen (0.063%), commercial
available durable wall lining (DWL), impregnated of existing bed-net with insecticide tablet,
KO TAB 123, indoor residual spraying (IRS) with Delthamethrin against a control group
Methods: A cluster randomized controlled design to measure sand fly density reduction at
intervention household as well as sand fly mortality by entomological methods.
Outcome measures/variables: reduction of sand fly density at intervention household and sand
fly corrected mortality on intervention surfaces compare to control households/conditions.
Status | Completed |
Enrollment | 202 |
Est. completion date | July 30, 2019 |
Est. primary completion date | April 30, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Filed Research Assistant will be listed all the study households in the selected study areas. - Only subjects who agree to participate and freely signed the consent form will be included in the study. Exclusion Criteria: - Subjects who will not agree to participate and freely signed the consent form will be included in the study. |
Country | Name | City | State |
---|---|---|---|
Bangladesh | Icddr,B Field Site | Mymensingh |
Lead Sponsor | Collaborator |
---|---|
International Centre for Diarrhoeal Disease Research, Bangladesh |
Bangladesh,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of Vector density (CDC light trap) | Based on sample size calculation, 18 households from each cluster will be selected randomly for sand fly density measurement at base line and 1,3, 6, 9, 12, 15, 18, 21 and 24 months after intervention | at base line and 1,3, 6, 9, 12, 15, 18, 21 and 24 months after intervention | |
Secondary | Corrected sand fly mortality | WHO Cone bio-assay will be done on the intervention surfaces and the control surfaces (at 18 households from each cluster) at 1, 3, 6, 9, 12, 15, 18, 21 and 24 months after intervention. | at 1,3, 6, 9, 12, 15, 18, 21 and 24 months after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02839603 -
Asymptomatic Leishmania Infection in HIV Patients
|
||
Completed |
NCT00370825 -
Combination Chemotherapy for the Treatment of Indian Kala-Azar
|
Phase 2 | |
Recruiting |
NCT05426577 -
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
|
||
Completed |
NCT01069198 -
A Community Trial for Visceral Leishmaniasis (VL)
|
N/A | |
Completed |
NCT01032187 -
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
|
Phase 4 | |
Completed |
NCT00371995 -
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
|
Phase 2 | |
Completed |
NCT00604955 -
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
|
Phase 4 | |
Completed |
NCT00342823 -
Immunogenetics of Visceral Leishmaniasis
|
N/A | |
Completed |
NCT04003532 -
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
|
||
Terminated |
NCT01980199 -
Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
|
Phase 2 | |
Completed |
NCT00255567 -
Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
|
Phase 3 | |
Not yet recruiting |
NCT06118749 -
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
|
||
Recruiting |
NCT04342715 -
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
|
||
Completed |
NCT02431143 -
Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
|
Phase 2 | |
Completed |
NCT01122771 -
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
|
Phase 3 | |
Completed |
NCT03636659 -
Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
|
Phase 1 | |
Not yet recruiting |
NCT01566552 -
Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
|
Phase 4 | |
Completed |
NCT00696969 -
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
|
Phase 3 | |
Completed |
NCT00318721 -
Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
|
N/A | |
Completed |
NCT00216346 -
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
|
Phase 3 |